Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 19 de 19
Filter
Add more filters










Publication year range
1.
SLAS Discov ; 24(9): 904-914, 2019 10.
Article in English | MEDLINE | ID: mdl-31318583

ABSTRACT

Organic cation transporters (OCTs) are membrane proteins with relevant physiological (because they accept neurotransmitters as substrate) and pharmacological (because of their interaction with drugs) roles. The human OCTs hOCT1 (SLC22A1/hOCT1) and hOCT2 (SLC22A2/hOCT2) are highly expressed in hepatic (hOCT1) and in renal and neuronal tissue (hOCT2), suggesting a possible role in modulating neurotransmitter activity in the liver, kidney, and brain, and their clearance from the blood. Even though there are several data demonstrating that OCTs are regulated under various patho-physiological conditions, it remains largely unknown which proteins directly interact with OCTs and thereby influence their cellular processing, localization, and function. In this work, using a mating-based split-ubiquitin yeast two-hybrid system, we characterized the potential interactome of hOCT1 and 2. It became evident that these OCTs share some potential interaction partners, such as the tetraspanins CD63 and CD9. Moreover, we confirmed interaction of hOCT2 with CD9 by fluorescence-activated cell sorting coupled with Förster resonance energy transfer analysis. Together with other proteins, tetraspanins build "tetraspanins webs" in the plasma membrane, which are able to regulate cellular trafficking and compartmentalization of interacting partners. While CD63 was demonstrated to mediate the localization of the hOCT2 to the endosomal system, we show here that co-expression of hOCT2 and CD9 led to strong cell surface localization of the transporter. These data suggest that tetraspanins regulate the cellular localization and function of OCTs. Co-localization of CD9 and hOCT was confirmed in tissues endogenously expressing proteins, highlighting the potential biological relevance of this interaction.


Subject(s)
Octamer Transcription Factor-1/metabolism , Organic Cation Transporter 2/metabolism , Tetraspanin 29/metabolism , Tetraspanins/metabolism , Animals , Cell Membrane/metabolism , Dogs , HEK293 Cells , Humans , Madin Darby Canine Kidney Cells , Membrane Proteins/metabolism , Protein Transport/physiology
2.
FASEB J ; 31(4): 1421-1433, 2017 04.
Article in English | MEDLINE | ID: mdl-28031320

ABSTRACT

CD63 is a ubiquitously expressed member of the tetraspanin superfamily. Using a mating-based split-ubiquitin-yeast 2-hybrid system, pull-down experiments, total internal reflection fluorescence microscopy, Förster resonance energy transfer, and biotinylation assays, we found that CD63 interacts with human organic cation transporter 2 (hOCT2), which transports endogenous and exogenous substrates, such as neurotransmitters and drugs in several epithelial cells. CD63 overexpression affects cellular localization of hOCT2 expressed in human embryonic kidney (HEK)293 cells. Studies with CD63-knockout mice indicate that in renal proximal tubules, CD63 determines the insertion of the mouse ortholog of the transporter into the proper membrane domain and mediates transporter regulation by trafficking processes. In polarized Madin-Darby kidney canine kidney (MDCK) epithelial cells, CD63 and hOCT2 colocalize with the small GTPase Rab4, which controls the rapid recycling from sorting endosomes back to the cell surface. Suitable negative and positive control experiments were performed for each experimental approach. Empty vector transfected cells and wild-type mice were used as control. CD63 seems to play a role in the recycling of hOCT2 from endosomes to the basolateral membrane in polarized epithelia. These data indicate that CD63 has a previously uncharacterized function in regulating trafficking of specific membrane proteins in polarized cells.-Schulze, U., Brast, S., Grabner, A., Albiker, C., Snieder, B., Holle, S., Schlatter, E., Schröter, R., Pavenstädt, H., Herrmann, E., Lambert, C., Spoden, G. A., Florin, L., Saftig, P., Ciarimboli, G. Tetraspanin CD63 controls basolateral sorting of organic cation transporter 2 in renal proximal tubules.


Subject(s)
Kidney Tubules, Proximal/metabolism , Organic Cation Transport Proteins/metabolism , Tetraspanin 30/metabolism , Animals , Cell Membrane/metabolism , Dogs , Endosomes/metabolism , Epithelial Cells/metabolism , HEK293 Cells , Humans , Kidney Tubules, Proximal/cytology , Madin Darby Canine Kidney Cells , Mice , Mice, Inbred C57BL , Organic Cation Transporter 2 , Protein Binding , Protein Transport , Tetraspanin 30/genetics , rab4 GTP-Binding Proteins/metabolism
3.
J Virol ; 90(23): 10629-10641, 2016 Dec 01.
Article in English | MEDLINE | ID: mdl-27654294

ABSTRACT

The human papillomavirus (HPV) capsid protein L2 is essential for viral entry. To gain a deeper understanding of the role of L2, we searched for novel cellular L2-interacting proteins. A yeast two-hybrid analysis uncovered the actin-depolymerizing factor gelsolin, the membrane glycoprotein dysadherin, the centrosomal protein 68 (Cep68), and the cytoskeletal adaptor protein obscurin-like 1 protein (OBSL1) as putative L2 binding molecules. Pseudovirus (PsV) infection assays identified OBSL1 as a host factor required for gene transduction by three oncogenic human papillomavirus types, HPV16, HPV18, and HPV31. In addition, we detected OBSL1 expression in cervical tissue sections and noted the involvement of OBSL1 during gene transduction of primary keratinocytes by HPV16 PsV. Complex formation of HPV16 L2 with OBSL1 was demonstrated in coimmunofluorescence and coimmunoprecipitation studies after overexpression of L2 or after PsV exposure. We observed a strong colocalization of OBSL1 with HPV16 PsV and tetraspanin CD151 at the plasma membrane, suggesting a role for OBSL1 in viral endocytosis. Indeed, viral entry assays exhibited a reduction of viral endocytosis in OBSL1-depleted cells. Our results suggest OBSL1 as a novel L2-interacting protein and endocytosis factor in HPV infection. IMPORTANCE: Human papillomaviruses infect mucosal and cutaneous epithelia, and the high-risk HPV types account for 5% of cancer cases worldwide. As recently discovered, HPV entry occurs by a clathrin-, caveolin-, and dynamin-independent endocytosis via tetraspanin-enriched microdomains. At present, the cellular proteins involved in the underlying mechanism of this type of endocytosis are under investigation. In this study, the cytoskeletal adaptor OBSL1 was discovered as a previously unrecognized interaction partner of the minor capsid protein L2 and was identified as a proviral host factor required for HPV16 endocytosis into target cells. The findings of this study advance the understanding of a so far less well-characterized endocytic pathway that is used by oncogenic HPV subtypes.


Subject(s)
Capsid Proteins/physiology , Cytoskeletal Proteins/physiology , Human papillomavirus 16/physiology , Oncogene Proteins, Viral/physiology , Capsid Proteins/genetics , Cell Line , Cytoskeletal Proteins/antagonists & inhibitors , Cytoskeletal Proteins/genetics , Endocytosis/physiology , Gene Knockdown Techniques , HeLa Cells , Host-Pathogen Interactions/physiology , Human papillomavirus 16/genetics , Humans , Keratinocytes/physiology , Keratinocytes/virology , Oncogene Proteins, Viral/genetics , Papillomavirus Infections/etiology , Two-Hybrid System Techniques , Virus Internalization
4.
Sci Rep ; 6: 32337, 2016 08 31.
Article in English | MEDLINE | ID: mdl-27578500

ABSTRACT

Human papillomaviruses enter host cells via a clathrin-independent endocytic pathway involving tetraspanin proteins. However, post-endocytic trafficking required for virus capsid disassembly remains unclear. Here we demonstrate that the early trafficking pathway of internalised HPV particles involves tetraspanin CD63, syntenin-1 and ESCRT-associated adaptor protein ALIX. Following internalisation, viral particles are found in CD63-positive endosomes recruiting syntenin-1, a CD63-interacting adaptor protein. Electron microscopy and immunofluorescence experiments indicate that the CD63-syntenin-1 complex controls delivery of internalised viral particles to multivesicular endosomes. Accordingly, infectivity of high-risk HPV types 16, 18 and 31 as well as disassembly and post-uncoating processing of viral particles was markedly suppressed in CD63 or syntenin-1 depleted cells. Our analyses also present the syntenin-1 interacting protein ALIX as critical for HPV infection and CD63-syntenin-1-ALIX complex formation as a prerequisite for intracellular transport enabling viral capsid disassembly. Thus, our results identify the CD63-syntenin-1-ALIX complex as a key regulatory component in post-endocytic HPV trafficking.


Subject(s)
Calcium-Binding Proteins/genetics , Cell Cycle Proteins/genetics , Endosomal Sorting Complexes Required for Transport/genetics , Papillomavirus Infections/genetics , Syntenins/genetics , Tetraspanin 30/genetics , Uterine Cervical Neoplasms/genetics , Calcium-Binding Proteins/chemistry , Carcinogenesis/genetics , Cell Cycle Proteins/chemistry , Endocytosis/genetics , Endosomal Sorting Complexes Required for Transport/chemistry , Female , HeLa Cells , Human papillomavirus 16/genetics , Human papillomavirus 16/pathogenicity , Human papillomavirus 18/genetics , Human papillomavirus 18/pathogenicity , Human papillomavirus 31/genetics , Human papillomavirus 31/pathogenicity , Humans , Multiprotein Complexes/chemistry , Multiprotein Complexes/genetics , Papillomavirus Infections/pathology , Papillomavirus Infections/virology , Protein Binding , Protein Transport/genetics , Tetraspanin 30/chemistry , Uterine Cervical Neoplasms/pathology , Uterine Cervical Neoplasms/virology
5.
Antimicrob Agents Chemother ; 58(5): 2905-11, 2014 May.
Article in English | MEDLINE | ID: mdl-24614368

ABSTRACT

Several viruses, including human papillomaviruses, depend on endosomal acidification for successful infection. Hence, the multisubunit enzyme vacuolar ATPase (V-ATPase), which is mainly responsible for endosome acidification in the cell, represents an attractive target for antiviral strategies. In the present study, we show that V-ATPase is required for human papillomavirus (HPV) infection and that uncoating/disassembly but not endocytosis is affected by V-ATPase inhibition. The infection inhibitory potencies of saliphenylhalamide, a proven V-ATPase inhibitor, and its derivatives, as well as those of other V-ATPase inhibitors, were analyzed on different HPV types in relevant cell lines. Variation in the selectivity indices among V-ATPase inhibitors was high, while variation for the same inhibitor against different HPV subtypes was low, indicating that broad-spectrum anti-HPV activity can be provided.


Subject(s)
Alphapapillomavirus/drug effects , Antiviral Agents/pharmacology , Vacuolar Proton-Translocating ATPases/antagonists & inhibitors , Viral Proteins/antagonists & inhibitors , Alphapapillomavirus/pathogenicity , Cell Line , Cell Survival/drug effects , Endocytosis/drug effects , HeLa Cells , Humans
6.
PLoS One ; 9(1): e88062, 2014.
Article in English | MEDLINE | ID: mdl-24498245

ABSTRACT

Antiviral activity has been demonstrated for different tannin-rich plant extracts. Since tannins of different classes and molecular weights are often found together in plant extracts and may differ in their antiviral activity, we have compared the effect against influenza A virus (IAV) of Hamamelis virginiana L. bark extract, fractions enriched in tannins of different molecular weights and individual tannins of defined structures, including pseudotannins. We demonstrate antiviral activity of the bark extract against different IAV strains, including the recently emerged H7N9, and show for the first time that a tannin-rich extract inhibits human papillomavirus (HPV) type 16 infection. As the best performing antiviral candidate, we identified a highly potent fraction against both IAV and HPV, enriched in high molecular weight condensed tannins by ultrafiltration, a simple, reproducible and easily upscalable method. This ultrafiltration concentrate and the bark extract inhibited early and, to a minor extent, later steps in the IAV life cycle and tannin-dependently inhibited HPV attachment. We observed interesting mechanistic differences between tannin structures: High molecular weight tannin containing extracts and tannic acid (1702 g/mol) inhibited both IAV receptor binding and neuraminidase activity. In contrast, low molecular weight compounds (<500 g/mol) such as gallic acid, epigallocatechin gallate or hamamelitannin inhibited neuraminidase but not hemagglutination. Average molecular weight of the compounds seemed to positively correlate with receptor binding (but not neuraminidase) inhibition. In general, neuraminidase inhibition seemed to contribute little to the antiviral activity. Importantly, antiviral use of the ultrafiltration fraction enriched in high molecular weight condensed tannins and, to a lesser extent, the unfractionated bark extract was preferable over individual isolated compounds. These results are of interest for developing and improving plant-based antivirals.


Subject(s)
Antiviral Agents , Hamamelis/chemistry , Human papillomavirus 16/metabolism , Influenza A virus/metabolism , Influenza, Human/drug therapy , Papillomavirus Infections/drug therapy , Plant Bark/chemistry , Plant Extracts , Tannins , Animals , Antiviral Agents/chemistry , Antiviral Agents/pharmacology , Dogs , Humans , Influenza, Human/metabolism , Influenza, Human/pathology , Madin Darby Canine Kidney Cells , Papillomavirus Infections/metabolism , Papillomavirus Infections/pathology , Plant Extracts/chemistry , Plant Extracts/pharmacology , Tannins/chemistry , Tannins/pharmacology
7.
Cell Microbiol ; 16(8): 1179-200, 2014 Aug.
Article in English | MEDLINE | ID: mdl-24444361

ABSTRACT

Human papillomaviruses (HPV) induce warts and cancers on skin and mucosa. The HPV16 capsid is composed of the proteins L1 and L2. After cell entry and virus disassembly, the L2 protein accompanies the viral DNA to promyelocytic leukaemia nuclear bodies (PML-NBs) within the host nuclei enabling viral transcription and replication. Multiple components of PML-NBs are regulated by small ubiquitin-like modifiers (SUMOs) either based on covalent SUMO modification (SUMOylation), or based on non-covalent SUMO interaction via SUMO interacting motifs (SIMs). We show here that the HPV16 L2 comprises at least one SIM, which is crucial for the L2 interaction with SUMO2 in immunoprecipitation and colocalization with SUMO2 in PML-NBs. Biophysical analysis confirmed a direct L2 interaction with SUMO substantiated by identification of potential L2-SUMO interaction structures in molecular dynamics simulations. Mutation of the SIM resulted in absence of the L2-DNA complex at PML-NB and in a loss of infectivity of mutant HPV16 pseudoviruses. In contrast, we found that L2 SUMOylation has no effect on L2 localization in PML-NBs and SUMO interaction. Our data suggest that the L2 SIM is important for L2 interaction with SUMO and/or SUMOylated proteins, which is indispensable for the delivery of viral DNA to PML-NBs and efficient HPV infection.


Subject(s)
Capsid Proteins/metabolism , Human papillomavirus 16/metabolism , Oncogene Proteins, Viral/metabolism , Papillomavirus Infections/pathology , Small Ubiquitin-Related Modifier Proteins/metabolism , Antigens, Viral/genetics , Antigens, Viral/metabolism , Capsid Proteins/genetics , Cell Line, Tumor , HEK293 Cells , HeLa Cells , Human papillomavirus 16/genetics , Humans , Molecular Dynamics Simulation , Nuclear Proteins/metabolism , Oncogene Proteins, Viral/genetics , Promyelocytic Leukemia Protein , Protein Structure, Tertiary , SUMO-1 Protein/metabolism , Transcription Factors/metabolism , Tumor Suppressor Proteins/metabolism , Zinc Fingers/physiology
8.
J Virol ; 87(8): 4461-74, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23388722

ABSTRACT

The minor capsid protein L2 of human papillomaviruses (HPVs) has multiple functions during the viral life cycle. Although L2 is required for effective invasion and morphogenesis, only a few cellular interaction partners are known so far. Using yeast two-hybrid screening, we identified the transcription factor TBX2 as a novel interaction partner of HPV type 16 (HPV16) L2. Coimmunoprecipitations and immunofluorescence analyses confirmed the L2-TBX2 interaction and revealed that L2 also interacts with TBX3, another member of the T-box family. Transcription of the early genes during HPV infection is under the control of an upstream enhancer and early promoter region, the long control region (LCR). In promoter-reporter gene assays, we observed that TBX2 and TBX3 repress transcription from the LCR and that this effect is enhanced by L2. Repression of the HPV LCR by TBX2/3 seems to be a conserved mechanism, as it was also observed with the LCRs of different HPV types. Finally, interaction of TBX2 with the LCR was detected by chromatin immunoprecipitation, and we found a strong colocalization of L2 and TBX2 in HPV16-positive cervical intraepithelial neoplasia (CIN) I-II tissue sections. These results suggest that TBX2/3 might play a role in the regulation of HPV gene expression during the viral life cycle.


Subject(s)
Capsid Proteins/metabolism , Host-Pathogen Interactions , Human papillomavirus 16/physiology , Oncogene Proteins, Viral/metabolism , T-Box Domain Proteins/metabolism , Transcription, Genetic , Virus Replication , HeLa Cells , Human papillomavirus 16/immunology , Human papillomavirus 16/pathogenicity , Humans , Immunoprecipitation , Microscopy, Fluorescence , Protein Interaction Mapping , Two-Hybrid System Techniques
9.
J Virol ; 87(6): 3435-46, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23302890

ABSTRACT

Human papillomavirus type 16 (HPV16) is the primary etiologic agent for cervical cancer. The infectious entry of HPV16 into cells occurs via a so-far poorly characterized clathrin- and caveolin-independent endocytic pathway, which involves tetraspanin proteins and actin. In this study, we investigated the specific role of the tetraspanin CD151 in the early steps of HPV16 infection. We show that surface-bound HPV16 moves together with CD151 within the plane of the membrane before they cointernalize into endosomes. Depletion of endogenous CD151 did not affect binding of viral particles to cells but resulted in reduction of HPV16 endocytosis. HPV16 uptake is dependent on the C-terminal cytoplasmic region of CD151 but does not require its tyrosine-based sorting motif. Reexpression of the wild-type CD151 but not mutants affecting integrin functions restored virus internalization in CD151-depleted cells. Accordingly, short interfering RNA (siRNA) gene knockdown experiments confirmed that CD151-associated integrins (i.e., α3ß1 and α6ß1/4) are involved in HPV16 infection. Furthermore, palmitoylation-deficient CD151 did not support HPV16 cell entry. These data show that complex formation of CD151 with laminin-binding integrins and integration of the complex into tetraspanin-enriched microdomains are critical for HPV16 endocytosis.


Subject(s)
Endocytosis , Human papillomavirus 16/physiology , Tetraspanin 24/metabolism , Virus Internalization , Cell Line , DNA Mutational Analysis , Gene Knockdown Techniques , Humans , Mutant Proteins/genetics , Mutant Proteins/metabolism , Tetraspanin 24/genetics
10.
Med Microbiol Immunol ; 201(4): 437-48, 2012 Nov.
Article in English | MEDLINE | ID: mdl-22972234

ABSTRACT

Papillomaviruses infect skin and mucosa where they induce warts and cancers. For entry to occur, they sequentially engage numerous host proteins, allowing them to deliver their genetic information into target cells. This multistep process starts with initial binding via its L1 major capsid protein, followed by structural changes of the capsid on the cell surface, engagement of different receptors, and endocytosis. The post-entry phase includes capsid disassembly, endosomal escape of a complex of the minor capsid protein L2 and the viral genome, its transport into the nucleus, and accumulation at nuclear substructures. This review summarizes the current knowledge of the papillomavirus entry pathway and the role of cellular proteins involved in this course of events.


Subject(s)
Host-Pathogen Interactions , Papillomaviridae/physiology , Virus Internalization , Epithelial Cells/virology , Humans
11.
PLoS One ; 7(7): e41760, 2012.
Article in English | MEDLINE | ID: mdl-22911853

ABSTRACT

Early detection and evaluation of brain tumors during surgery is crucial for accurate resection. Currently cryosections during surgery are regularly performed. Confocal laser endomicroscopy (CLE) is a novel technique permitting in vivo histologic imaging with miniaturized endoscopic probes at excellent resolution. Aim of the current study was to evaluate CLE for in vivo diagnosis in different types and models of intracranial neoplasia. In vivo histomorphology of healthy brains and two different C6 glioma cell line allografts was evaluated in rats. One cell line expressed EYFP, the other cell line was used for staining with fluorescent dyes (fluorescein, acriflavine, FITC-dextran and Indocyanine green). To evaluate future application in patients, fresh surgical resection specimen of human intracranial tumors (n = 15) were examined (glioblastoma multiforme, meningioma, craniopharyngioma, acoustic neurinoma, brain metastasis, medulloblastoma, epidermoid tumor). Healthy brain tissue adjacent to the samples served as control. CLE yielded high-quality histomorphology of normal brain tissue and tumors. Different fluorescent agents revealed distinct aspects of tissue and cell structure (nuclear pattern, axonal pathways, hemorrhages). CLE discrimination of neoplastic from healthy brain tissue was easy to perform based on tissue and cellular architecture and resemblance with histopathology was excellent. Confocal laser endomicroscopy allows immediate in vivo imaging of normal and neoplastic brain tissue at high resolution. The technology might be transferred to scientific and clinical application in neurosurgery and neuropathology. It may become helpful to screen for tumor free margins and to improve the surgical resection of malignant brain tumors, and opens the door to in vivo molecular imaging of tumors and other neurologic disorders.


Subject(s)
Brain Neoplasms/diagnosis , Brain Neoplasms/pathology , Diagnostic Imaging/methods , Microscopy, Confocal/methods , Animals , Biopsy , Cell Line, Tumor , Cerebellum/pathology , Glioma/diagnosis , Glioma/pathology , Humans , Male , Neoplasm Transplantation , Rats , Rats, Wistar , Transplantation, Homologous
12.
Antimicrob Agents Chemother ; 56(1): 75-82, 2012 Jan.
Article in English | MEDLINE | ID: mdl-21968369

ABSTRACT

Polyethylenimines are cationic polymers with potential as delivery vectors in gene therapy and with proven antimicrobial activity. However, the antiviral activity of polyethylenimines has not been addressed in detail thus far. We have studied the inhibitory effects of a linear 25-kDa polyethylenimine on infections with human papillomaviruses and human cytomegaloviruses. Preincubation of cells with polyethylenimine blocked primary attachment of both viruses to cells, resulting in a significant reduction of infection. In addition, the dissemination of human cytomegalovirus in culture cells was efficiently reduced by recurrent administration of polyethylenimine. Polyethylenimine concentrations required for inhibition of human papillomavirus and cytomegalovirus did not cause any cytotoxic effects. Polyethylenimines and their derivatives may thus be attractive molecules for the development of antiviral microbicides.


Subject(s)
Antiviral Agents/pharmacology , Cytomegalovirus Infections , Cytomegalovirus/drug effects , Papillomaviridae/drug effects , Polyethyleneimine/pharmacology , Virus Attachment/drug effects , Animals , Antiviral Agents/therapeutic use , COS Cells , Cations , Chlorocebus aethiops , Cytomegalovirus/physiology , Cytomegalovirus Infections/drug therapy , Cytomegalovirus Infections/prevention & control , Cytomegalovirus Infections/virology , Fibroblasts/drug effects , Fibroblasts/virology , HEK293 Cells , HeLa Cells , Humans , Keratinocytes/drug effects , Keratinocytes/virology , Microscopy, Fluorescence , Organ Specificity , Papillomaviridae/physiology , Papillomavirus Infections/drug therapy , Papillomavirus Infections/prevention & control , Papillomavirus Infections/virology , Polyethyleneimine/therapeutic use
13.
Cell Microbiol ; 13(1): 32-46, 2011 Jan.
Article in English | MEDLINE | ID: mdl-21166973

ABSTRACT

Human papillomaviruses (HPVs) are a family of small non-enveloped DNA viruses. Some genital HPV types, including HPV type 16 (HPV16), are the causative agent for the development of cancer at the site of infection. HPVs encode two capsid proteins, L1 and L2. After endocytic cell entry and egress from endosomes, L2 accompanies the viral DNA to the nucleus where replication is initiated. For cytoplasmic transport, L2 interacts with the microtubule network via the motor protein complex dynein. We have performed yeast two-hybrid screening and identified the dynein light chain DYNLT1 (previously called Tctex1) as interaction partner of HPV16 L2. Using co-immunoprecipitation and immunofluorescence colocalization studies we confirmed the L2-DYNLT1 interaction in mammalian cells. Further studies revealed that DYNLT3, the second member of the Tctex-light chain family, also interacts with L2 in vitro and in vivo, whereas other constituents of the dynein complex were not found to associate with L2. Depletion of DYNLT1 and DYNLT3 by specific siRNAs or cytosolic delivery of light chain-specific antibodies inhibited infection of HPV16. Therefore, this work identified two host cell proteins involved in HPV16 infection that are most likely required for transport purposes towards the nucleus.


Subject(s)
Capsid Proteins/metabolism , Dyneins/metabolism , Human papillomavirus 16/physiology , Oncogene Proteins, Viral/metabolism , Protein Interaction Mapping , Virus Replication , Fluorescent Antibody Technique , Gene Knockdown Techniques/methods , HeLa Cells , Humans , Immunoprecipitation , Microscopy, Confocal , Two-Hybrid System Techniques
14.
Exp Cell Res ; 315(16): 2765-74, 2009 Oct 01.
Article in English | MEDLINE | ID: mdl-19563799

ABSTRACT

The glycolytic key regulator pyruvate kinase M2 (M2-PK or PKM2) can switch between a highly active tetrameric and an inactive dimeric form. The transition between the two conformations regulates the glycolytic flux in tumor cells. We developed specific M2-PK-binding peptide aptamers which inhibit M2-PK, but not the 96% homologous M1-PK isoenzyme. In this study we demonstrate that, at normal blood glucose concentrations, peptide aptamer-mediated inhibition of M2-PK induces a significant decrease of the population doubling (PDL rate) and cell proliferation rate as well as an increase in cell size, whereas under glucose restriction an increase in PDL and cell proliferation rates but a decrease in cell size was observed. Moreover, M2-PK inhibition rescues cells from glucose starvation-induced apoptotic cell death by increasing the metabolic activity. These findings suggest that M2-PK is a metabolic sensor which regulates cell proliferation, cell growth and apoptotic cell death in a glucose supply-dependent manner.


Subject(s)
Apoptosis/physiology , Cell Proliferation , Energy Metabolism , Glucose/metabolism , Glycolysis , Isoenzymes/metabolism , Pyruvate Kinase/metabolism , Amino Acid Sequence , Animals , Aptamers, Peptide/genetics , Aptamers, Peptide/metabolism , Cell Size , Humans , Isoenzymes/genetics , Mice , Molecular Sequence Data , NIH 3T3 Cells , Pyruvate Kinase/genetics
15.
J Cell Biochem ; 107(2): 293-302, 2009 May 15.
Article in English | MEDLINE | ID: mdl-19308990

ABSTRACT

Pyruvate kinase M2 (M2-PK) controls the rate-limiting step at the end of the glycolytic pathway in normal proliferating and tumor cells. Other functions of M2-PK in addition to its role in glycolysis are little understood. The aim of this study was to identify new cellular interaction partners of M2-PK in order to discover novel links between M2-PK and cellular functions. Here we show that the SUMO-E3 ligase protein PIAS3 (inhibitor of activated STAT3) physically interacts with M2-PK and its isoenzyme M1-PK. Moreover, we demonstrate that endogenous SUMO-1-M2-PK conjugates exist in mammalian cells. Furthermore, we show that transient expression of PIAS3 but not the RING domain mutant PIAS3 (C299S, H301A) is consistent with nuclear localization of M2-PK and PIAS3 and M2-PK partially co-localize in the nucleus of these cells. This study suggests a link between PIAS3 and nuclear pyruvate kinase.


Subject(s)
Molecular Chaperones/metabolism , Protein Inhibitors of Activated STAT/metabolism , Pyruvate Kinase/metabolism , Signal Transduction/physiology , Blotting, Western , Fluorescent Antibody Technique , Humans , Immunoprecipitation , SUMO-1 Protein/metabolism , Two-Hybrid System Techniques , Ubiquitin-Protein Ligases/metabolism
16.
Int J Cancer ; 123(2): 312-321, 2008 Jul 15.
Article in English | MEDLINE | ID: mdl-18425820

ABSTRACT

Tumor cells express the glycolytic regulator pyruvate kinase subtype M2 (M2-PK), which can occur in a tetrameric form with high affinity to its substrate phosphoenolpyruvate (PEP) and a dimeric form with a low PEP affinity. The transition between both conformations contributes to the control of glycolysis and is important for tumor cell proliferation and survival. Here we targeted M2-PK by synthetic peptide aptamers, which specifically bind to M2-PK and shift the isoenzyme into its low affinity dimeric conformation. The aptamer-induced dimerization and inactivation of M2-PK led to a significant decrease in the PK mass-action ratio as well as ATP:ADP ratio in the target cells. Furthermore, the expression of M2-PK-binding peptide aptamers moderately reduced the growth of immortalized NIH3T3 cell populations by decelerating cell proliferation, but without affecting apoptotic cell death. Moreover, the M2-PK-binding peptide aptamers also reduced the proliferation rate of human U-2 OS osteosarcoma cells. In the present study, we developed the first specific inhibitors of the pyruvate kinase isoenzyme type M2 and present evidence that these inhibitors moderately decelerate tumor cell proliferation.


Subject(s)
Antineoplastic Agents/pharmacology , Aptamers, Peptide/pharmacology , Osteosarcoma/drug therapy , Protein Kinase Inhibitors/pharmacology , Pyruvate Kinase/antagonists & inhibitors , Adenosine Diphosphate/metabolism , Adenosine Triphosphate/metabolism , Amino Acid Sequence , Animals , Antineoplastic Agents/metabolism , Apoptosis/drug effects , Aptamers, Peptide/metabolism , Blotting, Western , Cell Line, Tumor , Cell Proliferation/drug effects , Glycolysis , Humans , Isoelectric Focusing , Isomerism , Mice , Molecular Sequence Data , NIH 3T3 Cells , Osteosarcoma/metabolism , Plasmids , Protein Kinase Inhibitors/metabolism , Protein Structure, Quaternary/drug effects , Pyruvate Kinase/metabolism , Tumor Stem Cell Assay
17.
Carcinogenesis ; 28(12): 2511-20, 2007 Dec.
Article in English | MEDLINE | ID: mdl-17827406

ABSTRACT

The E7 protein encoded by the oncogenic human papillomavirus type 16 has been shown to bind and inactivate insulin-like growth factor-binding protein-3 (IGFBP-3), the pro-apoptotic product of a tumour suppressor gene; however, the molecular mechanism underlying E7-induced inactivation of IGFBP-3 remained uncertain. In this study, we map the IGFBP-3-binding domain for E7 to the nuclear localization signal in the conserved C-terminal domain of IGFBP-3. Moreover, we demonstrate that both proteins interact in the nucleus and that E7 induces polyubiquitination and proteasome-dependent proteolysis of nuclear IGFBP-3 in cervical cancer cells. This leads to a dramatic shortening of the half-life of nuclear IGFBP-3, whereas the stability of an E7-non-binding IGFBP-3 mutant is not affected by E7. Finally, we show that E7-mediated destruction of nuclear IGFBP-3 correlates with the inhibition of IGFBP-3-induced apoptotic cell death. These data are consistent with E7-induced ubiquitin/proteasome-dependent inactivation of nuclear IGFBP-3.


Subject(s)
Apoptosis/physiology , Insulin-Like Growth Factor Binding Protein 3/physiology , Oncogene Proteins, Viral/physiology , Proteasome Endopeptidase Complex/metabolism , Ubiquitin/metabolism , Cell Line, Tumor , Cell Nucleus/metabolism , Female , Humans , Insulin-Like Growth Factor Binding Protein 3/genetics , Mutation , Oncogene Proteins, Viral/genetics , Papillomavirus E7 Proteins , Protein Binding , Protein Structure, Tertiary , Uterine Cervical Neoplasms
18.
Cancer Res ; 66(6): 3024-33, 2006 Mar 15.
Article in English | MEDLINE | ID: mdl-16540651

ABSTRACT

Insulin-like growth factor binding protein-3 (IGFBP-3), the product of a tumor suppressor target gene, can modulate cell proliferation and apoptosis by IGF-I-dependent and IGF-I-independent mechanisms. IGFBP-3 controls the bioavailability of IGFs in the extracellular environment and is known to be subject to degradation by various extracellular proteases. Although nuclear localization and functions of IGFBP-3 have been described in the past, we show as the novel features of this study that the abundance of nuclear IGFBP-3 is directly regulated by ubiquitin/proteasome-dependent proteolysis. We show that IGFBP-3 degradation depends on an active ubiquitin-E1 ligase, specific 26S proteasome inhibitors can efficiently stabilize nuclear IGFBP-3, and the metabolic half-life of nuclear IGFBP-3 is strongly reduced relative to cytoplasmic IGFBP-3. Nuclear IGFBP-3 is highly polyubiquitinated at multiple lysine residues in its conserved COOH-terminal domain and stabilized through mutation of two COOH-terminal lysine residues. Moreover, we show that IGFBP-3, if ectopically expressed in the nucleus, can induce apoptotic cell death. These results suggest that ubiquitin/proteasome-mediated proteolysis of IGFBP-3 may contribute to down-regulation of apoptosis.


Subject(s)
Apoptosis/physiology , Bone Neoplasms/metabolism , Insulin-Like Growth Factor Binding Protein 3/metabolism , Osteosarcoma/metabolism , Proteasome Endopeptidase Complex/metabolism , Ubiquitin/metabolism , Bone Neoplasms/enzymology , Bone Neoplasms/pathology , Cell Line, Tumor , Cell Nucleus/enzymology , Cell Nucleus/metabolism , Cytosol/enzymology , Cytosol/metabolism , Humans , Osteosarcoma/enzymology , Osteosarcoma/pathology , Ubiquitin-Activating Enzymes/metabolism
19.
FASEB J ; 18(10): 1120-2, 2004 Jul.
Article in English | MEDLINE | ID: mdl-15155561

ABSTRACT

High-risk human papillomaviruses (HPVs) are major etiological agents of cervical cancer. Despite excellent epidemiological evidence for a direct role of HPV-16 in cervical carcinogenesis, molecular pathways underlying carcinogenesis in vivo remain obscure. The E7 gene is required for immortalization and maintenance of the transformed phenotype in vitro; however, little is known about its role for tumorigenesis in vivo. The E7 gene codes for an unstable protein the abundance of which in cervical biopsies is unknown. We show here that E7 protein levels strongly increase during cervical carcinogenesis, underlining its fundamental role in cervical cancer. The E7 protein was found predominantly in the nucleus and to a minor extent in the cytoplasm in the cervical cancer cell line Ca Ski in vitro and in invasive cervical carcinoma in situ, suggesting that nuclear resident E7 plays a major role in cervical carcinogenesis in humans. The retinoblastoma protein (pRb) is a major E7-target in vitro. We show here that pRb expression is initially upregulated in LSIL and disappears in later stages concomitant with increased E7 levels, suggesting that E7-driven degradation of pRb is involved in cervical tumorigenesis in humans.


Subject(s)
Carcinoma, Squamous Cell/genetics , Cervix Uteri/virology , Gene Expression Regulation, Neoplastic , Gene Expression Regulation, Viral , Oncogene Proteins, Viral/physiology , Papillomaviridae/pathogenicity , Papillomavirus Infections/genetics , Retinoblastoma Protein/metabolism , Tumor Virus Infections/genetics , Uterine Cervical Dysplasia/genetics , Uterine Cervical Neoplasms/genetics , Animals , Antibodies, Viral/immunology , Biopsy , Bone Neoplasms/pathology , Bone Neoplasms/virology , Carcinoma, Squamous Cell/etiology , Carcinoma, Squamous Cell/pathology , Carcinoma, Squamous Cell/virology , Cell Differentiation , Cell Line, Tumor/metabolism , Cell Line, Tumor/virology , Cell Nucleus/virology , Cell Transformation, Neoplastic/genetics , Cell Transformation, Viral/genetics , Cervix Uteri/pathology , Disease Progression , Epithelial Cells/ultrastructure , Epithelial Cells/virology , Female , Genes, Retinoblastoma , Humans , Oncogene Proteins, Viral/biosynthesis , Oncogene Proteins, Viral/genetics , Oncogene Proteins, Viral/immunology , Osteosarcoma/pathology , Osteosarcoma/virology , Papillomaviridae/genetics , Papillomavirus E7 Proteins , Rabbits , Transfection , Uterine Cervical Neoplasms/etiology , Uterine Cervical Neoplasms/pathology , Uterine Cervical Neoplasms/virology , Uterine Cervical Dysplasia/etiology , Uterine Cervical Dysplasia/pathology , Uterine Cervical Dysplasia/virology
SELECTION OF CITATIONS
SEARCH DETAIL
...